Puromedicasp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-07-01
Share capital
158 000,00 PLN
Registered address
ul. Batorowska 30, 62-070 Dąbrowa, Poland
Electronic delivery address
AE:PL-12309-28131-RDEFB-17

Financials

Revenue history (in k)

Financial insight

  • Estonian CIT: Equity (Pasywa A) includes non-zero line items under Art. 28d of the Accounting Act — the filing indicates the lump-sum tax on company income.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.80mMedianUSD 266.29kAverageUSD 5.03m
Net profit
This companyUSD 407.14kMedianUSD 2.47kAverageUSD 348.58k
Operating costs
This companyUSD 1.38mMedianUSD 259.61kAverageUSD 4.45m
Assets
This companyUSD 664.48kMedianUSD 249.77kAverageUSD 3.86m

Bank accounts

Registered as a VAT taxpayer on 2018-06-05. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

10 public aid cases recorded, with a total value of $214,496.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,572
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,600
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,925

European Funds

ProjectEU co-financing
Promocja marki produktowej Puromedica na rynkach międzynarodowych w latach 2020-2022
$108.4K
Intensyfikacja sprzedaży suplementów diety marki PUROMEDICA na rynkach zagranicznych
$74,379

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Karolina Agnieszka Zarewicz — Attorney-in-fact (sole)
Igor Bondarenko — Attorney-in-fact
Magdalena Dominika Jagiełka — Attorney-in-fact (sole)
Tomasz Jerzy Jagiełka — President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the sole member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required. The President of the Management Board may always make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Tomasz Jerzy Jagiełka (50)
2,679$36,183.1484.7785%
Łukasz Kubot (44)
158$2,133.985%
Others
323$4,362.5110.2215%

Beneficial owners

Person
Tomasz Jerzy Jagiełka (50)

Competitors

Name
BIOUsp. z o.o.
Nikalabsp. z o.o.
Establo Pharmasp. z o.o.
Fharmfoodsp. z o.o.
Lab88sp. z o.o.
Bionatursp. z o.o. + limited partnership
Suplement.Iosp. z o.o.
Sanlifesp. z o.o.
Fresh Food Factorysp. z o.o.
Decomer Technologysp. z o.o.

Change history

DateEvent
2024-11-28Share capital change
2024-03-25Share capital change
2021-07-01Entered in the register

FAQ

Last updated: 2026-07-17